Jiangsu Nhwa Pharmaceutical Co., LTD (SHE:002262)
China · Delayed Price · Currency is CNY 22.03
-0.01 (-0.05%)
Aug 31, 2026, 3:04 PM CST
SHE:002262 Market Cap
SHE:002262 has a market cap or net worth of 22.38 billion as of August 31, 2026. Its market cap has decreased by -10.95% in one year.
Market Cap
22.38B
Enterprise Value
18.68B
Revenue
6.12B
Ranking
n/a
PE Ratio
20.21
Stock Price
22.03
ChartMarket Cap Chart
Since July 23, 2008, SHE:002262's market cap has increased from 1.26B to 22.38B, an increase of 1,669.70%. That is a compound annual growth rate of 17.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 22.38B | -8.70% |
| Dec 31, 2025 | 24.51B | -0.94% |
| Dec 31, 2024 | 24.74B | -9.45% |
| Dec 29, 2023 | 27.33B | 10.47% |
| Dec 30, 2022 | 24.74B | 56.87% |
| Dec 31, 2021 | 15.77B | -2.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 24.19B |
| Apeloa Pharmaceutical Co.,Ltd | 24.01B |
| Hubei Jumpcan Pharmaceutical | 23.09B |
| Walvax Biotechnology | 22.84B |
| Harbin Pharmaceutical Group | 22.67B |
| Tasly Pharmaceutical Group | 22.24B |
| Guangdong Zhongsheng Pharmaceutical | 21.97B |
| Jilin Aodong Pharmaceutical Group | 21.83B |